Understanding APIs: The Backbone of Every Drug Formulation

The active pharmaceutical ingredient is often referred to as the drug substance by those working in the pharmaceutical supply chain. It truly goes far beyond that straightforward label to someone who works as a formulator. It acts as the fundamental building block for the drug's stability, efficacy, and safety.

Excipients aid in a product's delivery process. However, overall therapeutic success is still controlled by the API. Manufacturers who produce FDFs, or finished dosage forms, must understand the subtleties of API quality. This is more than just determining purity levels. It is crucial to creating a product that dominates the market.

What Is an API?

The biologically active component of any medication product is known as an active pharmaceutical ingredient. Consider injectables, creams, tablets, and capsules. It creates the health effects that doctors intend.

Consider an Omeprazole capsule. The API is the omeprazole powder found inside. Excipients include the surrounding shell and any additional fillers.

The 70/30 Rule for Quality

The 70/30 rule for quality is used in formulation development. Experts frequently note that approximately 70% of a drug's effectiveness is determined by the physicochemical characteristics of the API. Modifications to excipients and processing procedures account for the remaining 30%.

Why Formulators Need the "Right" API

Finding the cheapest price per kilogram is only one aspect of sourcing an API. It involves determining which grade best suits your formulation approach. The physical attributes of your API are the foundation of your finished product for the following reasons:

1. Particle Size Distribution (PSD)

The particle size of an API directly impacts dissolution rate and bioavailability.

• Too coarse: The drug may not dissolve fast enough in the patient's stomach (low bioavailability).

• Too fine: The powder may become sticky and difficult to compress into tablets, leading to manufacturing defects like capping or sticking.

2. Polymorphism

Many APIs can exist in different crystalline forms (polymorphs). Different polymorphs can have vastly different solubilities. Using an inconsistent API source can lead to a batch failing dissolution tests because the crystal structure changed.

3. Impurity Profiling

Strict regulatory bodies (like the USFDA and EMA) are increasingly focused on impurity limits. High-quality APIs with low impurity profiles reduce the risk of forming toxic degradation products during the shelf-life of the medicine.